Risk factors for piperacillin/tazobactam-resistant Escherichia coli in ICU patients: a clinical study.
Intensive Care Med
; 29(7): 1164-8, 2003 Jul.
Article
em En
| MEDLINE
| ID: mdl-12774156
ABSTRACT
OBJECTIVE:
To determine risk factors of infections with piperacillin/tazobactam-resistant Escherichia coli in critical care patients.DESIGN:
Prospective, consecutive sample survey study.SETTING:
Surgical intensive care unit (ICU) in a university hospital. PATIENTS A consecutive series of 133 patients from whom culture results were positive for E. coli during their ICU stay.INTERVENTIONS:
None. MEASUREMENTS AND MAINRESULTS:
Multivariate logistic regression analysis identified the following significant independent factors associated with the emergence of a piperacillin/tazobactam-resistant Escherichia coli prior use of amoxicillin (odds ratio, 4.15) and amoxicillin/clavulanate (odds ratio, 3.25).CONCLUSIONS:
Treatment with amoxicillin or amoxicillin/clavulanate is a major risk factor for the detection of piperacillin/tazobactam-resistant E. coli in ICU patients.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Piperacilina
/
Resistência Microbiana a Medicamentos
/
Ácido Penicilânico
/
Escherichia coli
/
Unidades de Terapia Intensiva
/
Antibacterianos
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
En
Revista:
Intensive Care Med
Ano de publicação:
2003
Tipo de documento:
Article
País de afiliação:
França